ArticleBMJ open2026

Adjuvant short-course radiotherapy combined with chemotherapy and a PD-1 inhibitor for resected mucosal melanoma: study protocol for a single-arm, prospective, phase II trial.

Jiaojie Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.